跳至主要内容
临床试验/JPRN-UMIN000003218
JPRN-UMIN000003218已完成未知

To study the safety and efficacy of hypofractionated intensity modulated radiotherapy for patients with intermediate-risk prostate cancer. - To study the safety and efficacy of hypofractionated IMRT for patients with intermediate-risk prostate cancer.

Department of Radiation Oncology, The Cancer Institute Hospita, the Japanese Fundation for Cancer Reseach0 个研究点目标入组 30 人开始时间: 2010年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1) Small cell carcinoma 2) Previous or concurrent invasive cancers 3) Previous pelvic irradiation 4) Previous orchiectomy 5) Previous treatment of prostate cancer other than hormonal therapy 6) Cases judged by their physicians to be inappropriate as subjects

研究者

发起方
Department of Radiation Oncology, The Cancer Institute Hospita, the Japanese Fundation for Cancer Reseach

相似试验